Coloplast A/S (OTCMKTS:CLPBY) Stock Jumps 3.9% – What’s Next?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) rose 3.9% during mid-day trading on Monday. The company traded as high as $6.72 and last traded at $6.71. Approximately 24,521 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 439,344 shares. The stock had previously closed at $6.46.

Coloplast A/S Trading Up 3.0%

The stock has a 50 day simple moving average of $6.72 and a 200-day simple moving average of $6.45. The company has a current ratio of 1.56, a quick ratio of 0.94 and a debt-to-equity ratio of 1.51. The firm has a market capitalization of $15.62 billion, a P/E ratio of 18.19, a P/E/G ratio of 2.39 and a beta of 0.21.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.10. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. The business had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.11 billion. On average, equities research analysts forecast that Coloplast A/S Sponsored ADR will post 0.40 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy.